MoonLake Immunotherapeutics (MLTX) News Today $52.92 +2.48 (+4.92%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$53.00 +0.08 (+0.15%) As of 08/1/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Holdings Decreased by Federated Hermes Inc.August 1 at 7:23 AM | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 31 at 2:44 AM | marketbeat.comMoonLake Immunotherapeutics (MLTX) Projected to Post Quarterly Earnings on WednesdayJuly 30 at 5:46 AM | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to "Hold" at Redburn AtlanticJuly 29, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Now Covered by Analysts at Rothschild & Co RedburnJuly 29, 2025 | americanbankingnews.comMoonLake initiated with a Neutral at Rothschild & Co RedburnJuly 28, 2025 | msn.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Coverage Initiated by Analysts at Rothschild & Co RedburnJuly 28, 2025 | marketbeat.comMoonLake Immunotherapeutics (MLTX) Receives Neutral Rating from RedburnJuly 28, 2025 | gurufocus.comNew York State Common Retirement Fund Buys New Shares in MoonLake Immunotherapeutics (NASDAQ:MLTX)July 27, 2025 | marketbeat.comMoonLake Immunotherapeutics Sees Unusually Large Options Volume (NASDAQ:MLTX)July 27, 2025 | americanbankingnews.comTraders Buy Large Volume of MoonLake Immunotherapeutics Put Options (NASDAQ:MLTX)July 26, 2025 | marketbeat.comLegato Capital Management LLC Makes New $240,000 Investment in MoonLake Immunotherapeutics (NASDAQ:MLTX)July 26, 2025 | marketbeat.comVictory Capital Management Inc. Grows Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)July 25, 2025 | marketbeat.comRice Hall James & Associates LLC Purchases 26,383 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX)July 14, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 6, 2025 | marketbeat.comMoody Aldrich Partners LLC Makes New $2.16 Million Investment in MoonLake Immunotherapeutics (NASDAQ:MLTX)July 4, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 2.7% - Here's WhyJuly 3, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Bought by Harbor Capital Advisors Inc.June 11, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Buy" by AnalystsJune 11, 2025 | marketbeat.comCantor Fitzgerald Forecasts MLTX FY2026 EarningsJune 10, 2025 | marketbeat.comMoonLake Immunotherapeutics (MLTX) Hosts Investor Meetings Amid Merger Speculation | MLTX Stock NewsJune 9, 2025 | gurufocus.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 7, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Down 3.9% - What's Next?June 6, 2025 | marketbeat.comMoonLake Immunotherapeutics Breaks Above 200-Day Moving Average - Bullish for MLTXJune 5, 2025 | nasdaq.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Sees Large Volume Increase - Here's WhyJune 4, 2025 | marketbeat.comWellington Management Group LLP Lowers Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX)June 4, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)June 4, 2025 | marketbeat.comMoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma InterestJune 3, 2025 | seekingalpha.comConstellation and Meta, Merck, Snowflake: Trending TickersJune 3, 2025 | finance.yahoo.comMoonLake Immunotherapeutics Catapults On Rumored Merck TakeoverJune 3, 2025 | msn.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Gap Up - Here's What HappenedJune 3, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Outperform Rating from Royal Bank of CanadaJune 3, 2025 | marketbeat.comMerck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: ReportJune 3, 2025 | benzinga.comMerck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: ReportJune 3, 2025 | finance.yahoo.comMoonLake Immunotherapeutics stock surges on FT report of Merck buyout talksJune 2, 2025 | investing.comMerck held talks to buy biotech MoonLake for over $3 billion, FT reportsJune 2, 2025 | reuters.comBank of America Corp DE Sells 76,559 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX)June 2, 2025 | marketbeat.comNorthern Trust Corp Has $772,000 Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 31, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of MLTX Q2 EarningsMay 30, 2025 | marketbeat.comH.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PTMay 29, 2025 | finance.yahoo.comH.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PTMay 27, 2025 | insidermonkey.comBNP Paribas Financial Markets Takes $413,000 Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 27, 2025 | marketbeat.comWoodline Partners LP Grows Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 24, 2025 | marketbeat.comNuveen Asset Management LLC Boosts Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Invests $5.35 Million in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 22, 2025 | marketbeat.comMoonLake Immunotherapeutics (NASDAQ:MLTX) Upgraded by Wolfe Research to Outperform RatingMay 21, 2025 | marketbeat.comWexford Capital LP Purchases 10,000 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX)May 21, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Stock Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)May 21, 2025 | marketbeat.comWolfe Research Upgrades MoonLake Immunotherapeutics (MLTX)May 20, 2025 | msn.comWolfe Research Upgrades MoonLake Immunotherapeutics (MLTX) with a Bullish Outlook | MLTX Stock NewsMay 19, 2025 | gurufocus.com Get MoonLake Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MLTX and its competitors with MarketBeat's FREE daily newsletter. Email Address MLTX Media Mentions By Week MLTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLTX News Sentiment▼0.950.63▲Average Medical News Sentiment MLTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLTX Articles This Week▼134▲MLTX Articles Average Week Get MoonLake Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MLTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRNA News Today RDY News Today QGEN News Today VTRS News Today ASND News Today VRNA News Today BBIO News Today BPMC News Today ROIV News Today LEGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MoonLake Immunotherapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share MoonLake Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.